These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 25443220)
1. [Mucosal healling: a realistic aim or marketing myth?]. García-Sánchez V; Iglesias-Flores E Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():4-11. PubMed ID: 25443220 [TBL] [Abstract][Full Text] [Related]
2. Importance of mucosal healing in ulcerative colitis. Lichtenstein GR; Rutgeerts P Inflamm Bowel Dis; 2010 Feb; 16(2):338-46. PubMed ID: 19637362 [TBL] [Abstract][Full Text] [Related]
3. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063 [TBL] [Abstract][Full Text] [Related]
4. Definition and evaluation of mucosal healing in clinical practice. Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331 [TBL] [Abstract][Full Text] [Related]
5. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209 [TBL] [Abstract][Full Text] [Related]
6. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy. Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651 [TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis: epidemiology, diagnosis, and management. Feuerstein JD; Cheifetz AS Mayo Clin Proc; 2014 Nov; 89(11):1553-63. PubMed ID: 25199861 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study. Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390 [TBL] [Abstract][Full Text] [Related]
9. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993 [TBL] [Abstract][Full Text] [Related]
11. [Biological agents in ulcerative colitis. When to prescribe]. Barreiro-de Acosta M Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():36-42. PubMed ID: 25443225 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population. Juliao F; Marquez J; Aristizabal N; Yepes C; Zuleta J; Gisbert JP Digestion; 2013; 88(4):222-8. PubMed ID: 24281150 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262 [TBL] [Abstract][Full Text] [Related]
14. Review article: evolving concepts in treatment and disease modification in ulcerative colitis. Hanauer SB Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():15-21. PubMed ID: 18307645 [TBL] [Abstract][Full Text] [Related]
15. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients. Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174 [TBL] [Abstract][Full Text] [Related]
16. Current management of severe ulcerative colitis. Caprilli R; Viscido A; Latella G Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice. Bálint A; Farkas K; Palatka K; Lakner L; Miheller P; Rácz I; Hegede G; Vincze Á; Horváth G; Szabó A; Nagy F; Szepes Z; Gábor Z; Zsigmond F; Zsóri Á; Juhász M; Csontos Á; Szűcs M; Bor R; Milassin Á; Rutka M; Molnár T J Crohns Colitis; 2016 Jan; 10(1):26-30. PubMed ID: 26392413 [TBL] [Abstract][Full Text] [Related]
18. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Walsh A; Palmer R; Travis S Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528 [TBL] [Abstract][Full Text] [Related]
19. Mucosal Healing in Ulcerative Colitis--When Zero is Better. Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714 [TBL] [Abstract][Full Text] [Related]
20. Ulcerative colitis. Kelly S BMJ; 2012 May; 344():e2947. PubMed ID: 22577187 [No Abstract] [Full Text] [Related] [Next] [New Search]